Abivax Logo (full size)
Abivax Logo icon/symbol
Abivax Logo (full size) on a dark background
Abivax Logo icon/symbol on a dark background
About Abivax
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
July 6th, 2024
